A systematic literature review on the global epidemiology of Dravet syndrome and Lennox–Gastaut syndrome: Prevalence, incidence, diagnosis, and mortality
Epilepsia · 2024-05 · 65 (5) · 1240-1263
DOI: 10.1111/epi.17866 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Epilepsia, online erschienen am 22.01.2024. Verfasst von Joseph Sullivan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of California, San Francisco, San Francisco, California, USA. Hauptthemen laut MEDLINE: Lennox Gastaut Syndrome, Epilepsies, Myoclonic. Die Arbeit wurde bisher 80-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Takeda Pharmaceutical Company.
Abstract (Originalsprache)
Dravet syndrome (DS) and Lennox–Gastaut syndrome (LGS) are rare developmental and epileptic encephalopathies associated with seizure and nonseizure symptoms. A comprehensive understanding of how many individuals are affected globally, the diagnostic journey they face, and the extent of mortality associated with these conditions is lacking. Here, we summarize and evaluate published data on the epidemiology of DS and LGS in terms of prevalence, incidence, diagnosis, genetic mutations, and mortality and sudden unexpected death in epilepsy (SUDEP) rates. The full study protocol is registered on PROSPERO (CRD42022316930). After screening 2172 deduplicated records, 91 unique records were included; 67 provided data on DS only, 17 provided data on LGS only, and seven provided data on both. Case definitions varied considerably across studies, particularly for LGS. Incidence and prevalence estimates per 100 000 individuals were generally higher for LGS than for DS (LGS: incidence proportion = 14.5–28, prevalence = 5.8–60.8; DS: incidence proportion = 2.2–6.5, prevalence = 1.2–6.5). Diagnostic delay was frequently reported for LGS, with a wider age range at diagnosis reported than for DS (DS, 1.6–9.2 years; LGS, 2–15 years). Genetic screening data were reported by 63 studies; all screened for SCN1A variants, and only one study specifically focused on individuals with LGS. Individuals with DS had a higher mortality estimate per 1000 person‐years than individuals with LGS (DS, 15.84; LGS, 6.12) and a lower median age at death. SUDEP was the most frequently reported cause of death for individuals with DS. Only four studies reported mortality information for LGS, none of which included SUDEP. This systematic review highlights the paucity of epidemiological data available for DS and especially LGS, demonstrating the need for further research and adoption of standardized diagnostic criteria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, University of California, San Francisco, San Francisco, California, USA.
- Takeda Development Center Americas, Cambridge, Massachusetts, USA.
- Takeda Pharmaceuticals International, Zurich, Switzerland.
- Oxford PharmaGenesis, Oxford, UK.
- University College London, National Institute for Health and Care Research Biomedical Research Centre, London, UK.
ORCID-Profile: Joseph Sullivan, J Helen Cross
Förderung
- Takeda Pharmaceutical Company
Zitieren
APA
Sullivan, J., Benítez, A., Roth, J., Andrews, J. S., Shah, D., Butcher, E., Jones, A., & Cross, J. H. (2024). A systematic literature review on the global epidemiology of Dravet syndrome and Lennox–Gastaut syndrome: Prevalence, incidence, diagnosis, and mortality. Epilepsia, 65(5), 1240-1263. https://doi.org/10.1111/epi.17866
Vancouver
Sullivan J, Benítez A, Roth J, Andrews JS, Shah D, Butcher E, et al. A systematic literature review on the global epidemiology of Dravet syndrome and Lennox–Gastaut syndrome: Prevalence, incidence, diagnosis, and mortality. Epilepsia. 2024;65(5):1240-1263. doi:10.1111/epi.17866
BibTeX
@article{Sullivan2024,
author = {Sullivan, Joseph and Benítez, Arturo and Roth, Jeannine and Andrews, J Scott and Shah, Drishti and Butcher, Emma and Jones, Aimee and Cross, J Helen},
title = {A systematic literature review on the global epidemiology of Dravet syndrome and Lennox–Gastaut syndrome: Prevalence, incidence, diagnosis, and mortality},
journal = {Epilepsia},
year = {2024},
volume = {65},
number = {5},
pages = {1240--1263},
doi = {10.1111/epi.17866}
}
EUVIMED